Analysis of the efficacy of oral immunotherapy combined with Lactobacillus rhamnosus GG for patients with food allergy
Not Applicable
Recruiting
- Conditions
- food allergy
- Registration Number
- JPRN-UMIN000037482
- Lead Sponsor
- ational Hospital Organization Sagamihara National Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 15
Inclusion Criteria
Not provided
Exclusion Criteria
Decision of ineligibility by a physician
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Sustained unresponsiveness to middle dose after 12 months. Middle dose was defined as half of the whole egg, 25ml of cow's milk, 25g of udon noodle (Japanese wheat noodle), 3g of peanuts, or 3g of nuts.
- Secondary Outcome Measures
Name Time Method Intestinal microbiota Short-chain fatty acids (acetic acid, butyric acid, propionic acid, valeric acid) in the serum Changes in specific IgE, IgG, and IgG4 titer Frequency of adverse reactions during therapy